CTD-MT 12.5/50/40 Tablet ER

Overview CTD-MT 12.5/50/40 Tablet ER

The extended-release tablet CTD-MT 12.5/50/40 is a multi-component medication employed in managing hypertension. Its mechanism involves vasodilation (blood vessel relaxation) and enhanced cardiac output, simultaneously promoting diuresis (fluid excretion) and electrolyte balance. This medication may be ingested with or without food, but consistent timing optimizes efficacy. Due to its diuretic effect, daytime administration, preferably at least four hours before sleep, is recommended to minimize nocturnal urination. Dosage and frequency are determined by your physician based on individual needs and should be followed precisely for the prescribed duration. Commonly reported adverse effects include gastrointestinal discomfort (nausea, altered taste, diarrhea), requiring careful monitoring of renal function and electrolyte levels. Optimal outcomes necessitate lifestyle modifications, including a balanced diet, regular physical activity, and smoking cessation; increased fluid intake is also advised to mitigate potential dehydration. Prior to commencement, inform your physician of any pregnancy, circulatory disorders, hepatic or renal impairment, and all concurrent medications, as interactions may influence efficacy or safety.

Uses of CTD-MT 12.5/50/40 Tablet ER

Elevated arterial blood pressure

Major Benefits of CTD-MT 12.5/50/40 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the CTD-MT 12.5/50/40 Extended-Release tablet whole; avoid chewing, crushing, or breaking it. While this medication can be taken with or without food, consistent timing is recommended for optimal results.

Common Side effects of CTD-MT 12.5/50/40 Tablet ER:

• Nausea
• Taste change
• Diarrhea
• Upset stomach
• Headache
• Dizziness
• Weakness
• Cold extremities
• Numbness of extremity
• Increased uric acid level in blood
• Increased blood lipid level
• Decreased magnesium level in blood
• Slow heart rate
• Decreased sodium level in blood
• Decreased blood pressure

How to use CTD-MT 12.5/50/40 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the CTD-MT 12.5/50/40 Tablet ER whole; avoid chewing, crushing, or breaking it. This extended-release tablet can be administered with or without food, though consistent timing is recommended.

How CTD-MT 12.5/50/40 Tablet ER works:

Extended-release tablets of CTD-MT (12.5/50/40 mg) contain chlorthalidone, metoprolol succinate, and telmisartan, a triple drug formulation for effective blood pressure management.

What if you forget to take CTD-MT 12.5/50/40 Tablet ER :

Should you forget to take a CTD-MT 12.5/50/40 Tablet ER, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.